22 Programs

  • Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia

    Explore program
  • Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oral SERDs for Breast Cancer

    Explore program
  • Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in EGFR-Mutant Non-Small Cell Lung Cancer

    Explore program
  • Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer

    Explore program